ALLIANCEBERNSTEIN L.P. - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 158 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.5%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$31,045,127
+2453.4%
808,046
+1438.5%
0.01%
+1200.0%
Q1 2023$1,215,838
-11.6%
52,5200.0%0.00%0.0%
Q4 2022$1,376,024
+99.4%
52,520
+49.5%
0.00%
Q3 2022$690,000
+12.4%
35,1200.0%0.00%
Q2 2022$614,000
+11.0%
35,120
+3.8%
0.00%
Q1 2022$553,000
+0.5%
33,820
+0.3%
0.00%
Q4 2021$550,000
+36.5%
33,720
+6.6%
0.00%
Q3 2021$403,000
-9.6%
31,6200.0%0.00%
Q2 2021$446,000
+18.6%
31,620
+30.6%
0.00%
Q1 2021$376,000
-2.1%
24,2200.0%0.00%
Q4 2020$384,00024,2200.00%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 14,158$12,782,0005.70%
Samsara BioCapital, LLC 3,168,388$44,738,0005.52%
FRAZIER MANAGEMENT LLC 1,100,000$15,532,0001.43%
Altium Capital Management LP 416,567$5,882,0001.36%
Affinity Asset Advisors, LLC 200,000$2,824,0001.01%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 170,821$2,412,0000.64%
Vivo Capital, LLC 872,151$12,315,0000.53%
EcoR1 Capital, LLC 931,650$13,155,0000.49%
ARMISTICE CAPITAL, LLC 1,236,000$17,452,0000.31%
Rubric Capital Management LP 325,863$4,601,0000.29%
View complete list of CHINOOK THERAPEUTICS INC shareholders